Reproducibility of the Nottingham modification of the Scarff-Bloom-Richardson histological grading system and the complementary value of Ki-67 to this system
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 15
- DOI:
- 10.3760/cma.j.issn.0366-6999.2010.15.005
- Key Word:
- invasive breast cancer;histological grading system;reproducibility;Ki-67;prognosis
Abstract： Background The reproducibility of the Nottingham modification of the Scarff-Bloom-Richardson (NSBR) histological grading system for invasive breast cancer (IBC) adopted by the World Health Organization (WHO) has previously not been studied in Chinese hospitals. The proliferation marker, Ki-67, has been widely applied in detecting IBC. The objective of this study was to assess the reproducibility of the NSBR system among Chinese pathologists and the complementary value that Ki-67 brings to this system.Methods Four general pathologists graded 100 IBC cases independently, which had previously been graded by specialists in breast pathology. The interobserver reproducibility among four general pathologists and pairwise reproducibility between each of them and the specialists were assessed. The Ki-67 labeling index (Ki-67LI) was determined by immunohistochemistry, and its correlations with histological grade and survival were determined.Results With respect to interobserver reproducibility, NSBR grading was fairly reproducible (kappa=0.34); as for the components of NSBR grading, agreement was best for tubule formation (kappa=0.46), intermediate for nuclear pleomorphism (kappa=0.42), and poorest for mitotic count (kappa=0.28). In terms of pairwise reproducibility, agreement was fair to substantial with NSBR grading (kappa=0.30-0.69) and nuclear pleomorphism (kappa=0.28-0.69), moderate to substantial for tubule formation (kappa=0.51-0.78), and slight to substantial for mitotic count (kappa=0.19-0.71).There were characteristic Ki-67LI ranges for grades 1,2 and 3 tumors. Univariate analysis showed that Ki-67 was able to divide grade 2 patients into two different prognostic subgroups. Multivariate analysis of grade 2 patients with negative lymph node demonstrated that Ki-67 was an independent prognosticator for overall survival.Conclusions The reproducibility of grading by general pathologists could be enhanced. Specialization in breast pathology is essential for accurate grading and treatment for IBC. Ki-67, with proven prognostic significance, adds complementary value to the NSBR system.
- [1]de-Azambuja E,Cardoso F,de-Castro-G Jr,etc.Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.[J].2007,96(10).
- [2]Smeds J,Bergh J,Wirapati P,etc.Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.[J].2006,98(4).
- [3]Zhu SX,Lashkari D,Eisen MB,etc.Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.[J].1999,96(16).
- [4]Cheang MC,Chia SK,Voduc D,etc.Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.[J].2009,101(10).
- [5]J R, Landis,G G, Koch.The measurement of observer agreement for categorical data.[J].1977,33.
- [6]Iqbal S,Prescott RJ,Marson LP,etc.MIB-1 assessments in breast cancers.[J].2002,11(3).
- [7]Yip G,Bay BH,Selvarajan S,etc.Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death.[J].2005,18(3).
- [8]Woods R,Ravdin P,Yerushalmi R.Ki67 in breast cancer: prognostic and predictive potential.[J].2010,11(2).
- [9]Magliocco AM,Tambasco M.Relationship between tumor grade and computed architectural complexity in breast cancer specimens.[J].2008,39(5).
- [10]Wiesner FG,Magener A,Jud S,etc.Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients.[J].2009,18(2).
- [11]Chowdhury N,Kini H,Lobo FD,etc.Impact of an increase in grading categories and double reporting on the reliability of breast cancer grade.[J].2007,115(4).
- [12]H F, Frierson,R A, Wolber,K W, Berean,etc.Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.[J].1995,103.
- [13]Roviello F,De-Stefano A,Marrelli D,etc.Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.[J].2008,34(12).
- [14]Tavassoli FA,Gwin K,Pinto M.Complementary value of the Ki-67 proliferation index to the oncotype DX recurrence score.[J].2009,17(4).
- [15]Goldhirsch A,Gelber RD,Ingle JN.Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.[J].2009,20(8).
- [16]Klintman M,Bendahl PO,Grabau D,etc.The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.[J].2010,23(2).
- [17]Longacre TA,Ennis M,Quenneville LA,etc.Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study.[J].2006,19(2).
- [18]Kimler BF,Mayo MS,Jewell WR,etc.Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.[J].2007,450(6).
- [19]P Robbins,S Pinder,N de Klerk,etc.Histological grading of breast carcinomas: A study of interobserver agreement[J].1995,26(8).